ERD-3111

• Target :

  PROTACs|||Estrogen Receptor/ERR

• Related Pathways :

  PROTAC|||Endocrinology/Hormones

• Bioactivity :

  ERD-3111 (Compound 44), an orally active PROTAC ER? degrader (DC50: 0.5 nM), exhibits efficacy in inhibiting tumor growth in both the parental MCF-7 xenograft model harboring wild-type ER and two ESR1-mutated mouse models. This compound has utility in the investigation of ER+ breast cancer [1].

• Smiles :

  C(C(F)F)N1[C@@H](C2=C(C3=C(C=C2)NN=C3)C[C@H]1C)C4=C(F)C=C(C=C4F)N5CCC6(CC5)CCN(C(CN7CC=8C(C7)=CC9=C(C8)C(=O)N(C9=O)C%10C(=O)NC(=O)CC%10)=O)CC6

• Molecular Formula :

  C45H46F4N8O5

• Molecular Weight :

  854.89

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  2832865-25-3